Magnetic helmet shrank a malignant tumor in the world’s first test

Technology has often been a powerful ally in the various fields of medicine. In fact, we already know many devices capable of detecting a multitude of diseases, as well as acting against them. This time, in a world premiere, a magnetic helmet managed to reduce a malignant tumor.

The device can be easily operated at home.

The brain is the main organ of the human being, but also one of the most sensitive. For this reason, all investigations and methods aimed at its preservation become very relevant. As part of the latest neurological discovery, researchers used a helmet that generates a magnetic field, with the aim of shrinking a malignant tumor.

Although the 53-year-old patient did not survive due to an unrelated injury, the brain autopsy revealed that the procedure had removed 31% of the mass in a short period of time. So this test was the first non-invasive intervention to try to cure glioblastoma, a malignant brain cancer.

Patient who used the magnetic helmet in the tests

Malignant tumor reduced with a magnetic helmet

The magnetic helmet features three rotating magnets connected to an electronic controller, based on a microprocessor and operated by a rechargeable battery. The patient wore the helmet for five weeks at a clinic and then at home.

Initially, the therapy promoted by the magnetic helmet was used for 2 hours a day, after which it was increased to a maximum of 6 hours. During this period, the patient's tumor mass and volume shrank by nearly a third.

According to the researchers, who received approval from the US Food and Drug Administration (FDA) to use the magnetic helmet, one day, it could help treat brain cancer without resorting to radio or chemotherapy.

Our results open up a new world of non-invasive and non-toxic therapy with many exciting possibilities for the future.

Disse David S. Baskin, autor correspondente e diretor do Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment no Department of Neurosurgery do Houston Methodist Neurological Institute.

Read too: